Adipocyte plasma membrane-associated protein (APMAP) (APMAP)

Adipocyte plasma membrane-associated protein (APMAP), also known as C20orf3, is a 46 kDa type II transmembrane protein that is highly expressed in adipose tissue and plays a critical role in adipocyte differentiation and metabolic regulation. It is localized to both the plasma membrane and the endoplasmic reticulum, where it exhibits strong arylesterase activity and interacts with proteins involved in the extracellular matrix and insulin signaling pathways. APMAP is essential for the induction of adipogenesis, with its expression increasing significantly during the transition from preadipocytes to mature adipocytes. In metabolic disorders such as obesity and gestational diabetes, APMAP levels are frequently down-regulated, which is associated with impaired insulin sensitivity and increased pro-inflammatory signaling. Beyond its metabolic functions, APMAP has been identified as a key host factor for human cytomegalovirus (HCMV) infection, facilitating the early stages of viral entry into host cells. Experimental therapeutic strategies, such as the use of aptamer-functionalized nanoparticles and RNA interference, are currently being explored to modulate APMAP activity for the treatment of obesity and related metabolic complications.

Other names

C20orf3BSCvProtein DD16Adipocyte plasma membrane-associated protein

Modulation of adipocyte differentiation, enhancement of insulin sensitivity, and inhibition of viral entry by facilitating or blocking APMAP-mediated signaling and transport processes.